Breast cancer
A study comparing intravenous iron and oral iron to treat iron deficiency anemia in women with early breast cancer receiving chemotherapy
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Basavatarakam Indo-American Cancer Hospital and Research InstituteHyderabad, TelanganaDirections ↗
Registry summary (technical)
BRIGHT-Fe Breast cancer Randomized trial of IV vs oral Iron (ferric derisomaltose vs iron polypeptide) for hemoglobin recovery, chemo dose intensity, and transfusion avoidance in early breast cancer. - BRIGHT-Fe
Sponsor: Basavatarakam Indo American Cancer Hospital & Research Institute
CTRI/2026/02/104238 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026